keyword
https://read.qxmd.com/read/38649821/long-non-coding-rna-sox2ot-in-tamoxifen-resistant-breast-cancer
#21
JOURNAL ARTICLE
Jeeyeon Lee, Eun-Ae Kim, Jieun Kang, Yee Soo Chae, Ho Yong Park, Byeongju Kang, Soo Jung Lee, In Hee Lee, Ji-Young Park, Nora Jee-Young Park, Jin Hyang Jung
Hormone receptor (HR)-positive breast cancer can become aggressive after developing hormone-treatment resistance. This study elucidated the role of long non-coding RNA (lncRNA) SOX2OT in tamoxifen-resistant (TAMR) breast cancer and its potential interplay with the tumor microenvironment (TME). TAMR breast cancer cell lines TAMR-V and TAMR-H were compared with the luminal type A cell line (MCF-7). LncRNA expression was assessed via next-generation sequencing, RNA extraction, lncRNA profiling, and quantitative RT-qPCR...
April 22, 2024: BMC molecular and cell biology
https://read.qxmd.com/read/38649340/daratumumab-based-quadruplet-therapy-for-transplant-eligible-newly-diagnosed-multiple-myeloma-with-high-cytogenetic-risk
#22
JOURNAL ARTICLE
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob Laubach, Timothy M Schmidt, Douglas W Sborov, Eva Medvedova, Brandi Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano J Costa, Saad Z Usmani, Paul G Richardson, Peter M Voorhees
In the MASTER study (NCT03224507), daratumumab+carfilzomib/lenalidomide/dexamethasone (D-KRd) demonstrated promising efficacy in transplant-eligible newly diagnosed multiple myeloma (NDMM). In GRIFFIN (NCT02874742), daratumumab+lenalidomide/bortezomib/dexamethasone (D-RVd) improved outcomes for transplant-eligible NDMM. Here, we present a post hoc analysis of patients with high-risk cytogenetic abnormalities (HRCAs; del[17p], t[4;14], t[14;16], t[14;20], or gain/amp[1q21]). Among 123 D-KRd patients, 43.1%, 37...
April 22, 2024: Blood Cancer Journal
https://read.qxmd.com/read/38649152/screening-and-diagnosis-of-rare-thalassemia-variants
#23
JOURNAL ARTICLE
Haishen Tang, Yi Xiong, Jiaqi Tang, Xiaohong Wang, Ya Wang, Liping Huang, Runli Wang, Degang Wang
CONTEXT.—: Rare thalassemia subtypes are often undiagnosed because conventional testing methods can only identify 23 common types of α- and β-thalassemia. OBJECTIVE.—: To assess a comprehensive approach for the screening and diagnosis of rare thalassemia. DESIGN.—: The study cohort included 72 individuals with suspected rare thalassemia variants. Screening was conducted by next-generation sequencing (NGS) combined with third-generation sequencing (TGS) and chromosomal microarray analysis (CMA)/copy number variation sequencing...
April 23, 2024: Archives of Pathology & Laboratory Medicine
https://read.qxmd.com/read/38648550/decoding-the-structural-diversity-a-new-horizon-in-antimicrobial-prospecting-and-mechanistic-investigation
#24
JOURNAL ARTICLE
Ziying Qiu, Rongkun Huang, Yuxuan Wu, Xinghao Li, Chunyu Sun, Yunqi Ma
The escalating crisis of antimicrobial resistance (AMR) underscores the urgent need for novel antimicrobials. One promising strategy is the exploration of structural diversity, as diverse structures can lead to diverse biological activities and mechanisms of action. This review delves into the role of structural diversity in antimicrobial discovery, highlighting its influence on factors such as target selectivity, binding affinity, pharmacokinetic properties, and the ability to overcome resistance mechanisms...
April 22, 2024: Microbial Drug Resistance: MDR: Mechanisms, Epidemiology, and Disease
https://read.qxmd.com/read/38648460/differences-of-ocular-oscillations-and-neuro-retinal-structures-in-patients-with-nystagmus-caused-by-gpr143-and-frmd7-gene-variants
#25
JOURNAL ARTICLE
Lijuan Huang, Biru Xu, Ningdong Li
PURPOSE: Mutations of G protein-coupled receptor 143 (GPR143) and FERM domain containing 7 (FRMD7) may result in congenital nystagmus (CN) in the first 6 months of life. We aimed to compare the differences in ocular oscillations between patients with these two gene mutations as well as the functional and structural changes in their retinas and visual pathways. METHODS: Medical records were retrospectively reviewed to identify patients of congenital nystagmus with confirmed mutations in either GPR143 or FMRD7 genes from January 2018 to May 2023...
May 1, 2024: Indian Journal of Ophthalmology
https://read.qxmd.com/read/38647991/rare-multi-fungal-sepsis-a-case-of-triple-impact-immunoparalysis
#26
JOURNAL ARTICLE
Bretislav Lipovy, Martin Hladik, Katerina Vyklicka, Iva Kocmanova, Martina Lengerova, Leos Kren, Michal Srnik, Jan Bohm, Petr Andrla, Petra Borilova Linhartova
Patients with burn injury and inhalation injury are highly susceptible to infectious complications, including opportunistic pathogens, due to the loss of skin cover and mucosal damage of respiratory tract as well as the disruption of homeostasis. This case report, a 34-year-old man suffered critical burns, provides the first literature description of triple-impact immunoparalysis (critical burns, inhalation injury, and SARS-CoV-2 infection), leading to a lethal multifocal infection caused by several fungi including very rare environmental representatives Metschnikowia pulcherrima and Wickerhamomyces anomalus...
April 22, 2024: Folia Microbiologica
https://read.qxmd.com/read/38647270/identification-of-a-new-hla-b-allele-hla-b-35-594
#27
JOURNAL ARTICLE
Maria Loginova, Daria Smirnova, Igor Paramonov, Andrey Belyaev
A novel HLA-B*35 allele, officially designated HLA-B*35:594, was identified by next-generation sequencing.
April 2024: HLA
https://read.qxmd.com/read/38647251/identification-of-the-novel-hla-c-allele-hla-c-12-351q-using-next-generation-sequencing
#28
JOURNAL ARTICLE
Saber AlZahrani, Hassan Alharbi, Rafah Bamrdouf, Ali Ajebi, Amani Mohammed
The novel allele HLA-C*12:351Q differs from HLA-C*12:02:02:01 by a single nucleotide deletion in exon 5.
April 2024: HLA
https://read.qxmd.com/read/38646679/a-rare-case-of-a-malignant-epithelioid-neoplasm-with-an-underlying-novel-ewsr1-zbt44-fusion-identified-on-next-generation-sequencing-ngs
#29
JOURNAL ARTICLE
Bharat Rekhi, Akhil Santosh, Sameer Rastogi
The clinicopathological spectrum of undifferentiated round cell sarcomas of bone and soft tissues is expanding after the 5th edition of the WHO classification. A 23-year-old male patient presented with a lump in his left thigh of 3 months' duration. Radiological examination revealed a well-defined, solid-cystic lobulated, soft tissue lesion in the proximal medial region of his left thigh, measuring 7.7 cm in the largest dimension. The referring diagnosis was an epithelioid sarcoma. Histopathological review of the tumor sections revealed a cellular tumor composed of malignant epithelioid to focally "rhabdoid-like" cells in a variable hyalinized and myxoid stroma with geographic areas of necrosis...
April 22, 2024: International Journal of Surgical Pathology
https://read.qxmd.com/read/38646532/case-report-novel-compound-heterozygous-il1rn-mutations-as-the-likely-cause-of-a-lethal-form-of-deficiency-of-interleukin-1-receptor-antagonist
#30
JOURNAL ARTICLE
Elena Urbaneja, Nuria Bonet, Manuel Solis-Moruno, Anna Mensa-Vilaro, Iñaki Ortiz de Landazuri, Marc Tormo, Rocio Lara, Susana Plaza, Virginia Fabregat, Jordi Yagüe, Ferran Casals, Juan I Arostegui
Undiagnosed monogenic diseases represent a challenging group of human conditions highly suspicious to have a genetic origin, but without conclusive evidences about it. We identified two brothers born prematurely from a non-consanguineous healthy couple, with a neonatal-onset, chronic disease characterized by severe skin and bone inflammatory manifestations and a fatal outcome in infancy. We conducted DNA and mRNA analyses in the patients' healthy relatives to identify the genetic cause of the patients' disease...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38646498/metastatic-breast-cancer-with-double-heterozygosity-for-the-brca1-and-brca2-genes-responding-to-olaparib-a-case-report
#31
Bin Shao, Lijun Di
Olaparib was the first poly ADP-ribose polymerase inhibitor approved for patients with cancer with mutations in either BRCA1 or BRCA2 in China. To the best of our knowledge, however, no study has described the efficacy of olaparib for patients with breast cancer with double mutations in BRCA1 and BRCA2 . The present case report describes a patient with breast cancer with deleterious germline mutations in both BRCA1 and BRCA2 . The 56-year-old patient with multiple metastatic breast cancer underwent breast cancer resection with 12 years interval between removal of the left and right breast...
June 2024: Oncology Letters
https://read.qxmd.com/read/38645890/the-first-case-report-of-inactive-nontuberculous-mycobacterial-pulmonary-disease-ntm-pd-in-a-pneumoconiosis-patient-caused-by-mycobacterium-europaeum-in-china
#32
Jiaqing Zhou, Huan Xu, Wen Du, Lijun Peng
We reported a 51-year-old male electric welder with stage I pneumoconiosis, who had no significant cough, sputum, fever, chest pain, or other discomfort. However, regular physical examination at our hospital revealed bilateral pulmonary nodules with cavity formation. Blood routine, liver or kidney function, and infection-related biomarkers, including interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and procalcitonin (PCT), were normal. Sputum and alveolar lavage fluid (BALF) acid-fast bacilli (AFB) smears, BALF Mycobacterium tuberculosis (TB) PCR, and T-SPOT...
2024: Infection and Drug Resistance
https://read.qxmd.com/read/38645888/a-rare-case-report-of-disseminated-nocardia-farcinica-granulomatous-hepatitis-and-clinical-management-experience
#33
Rui Juan Song, Guang Lin Zhang
BACKGROUND: Nocardiosis is primarily an opportunistic infection affecting immunocompromised individuals, with a predilection for the lungs, brain, or skin in those with compromised immune function. Granulomatous hepatitis caused by Nocardia is a rare clinical manifestation. This study aims to provide a systematic overview of the clinical features of Nocardiosis caused by Nocardia farcinica, enhancing our understanding of this disease. METHODS: We report a case of a 75-year-old male with no underlying diseases presenting with a history of "recurrent fever for more than 4 months", along with fatigue, poor appetite, and pleural and abdominal effusion...
2024: Infection and Drug Resistance
https://read.qxmd.com/read/38645788/protective-effects-of-jing-si-herbal-tea-in-inflammatory-cytokines-induced-cell-injury-on-normal-human-lung-fibroblast-via-multiomic-platform-analysis
#34
JOURNAL ARTICLE
Chien-Hao Wang, Jai-Sing Yang, Chao-Jung Chen, San-Hua Su, Hsin-Yuan Yu, Yu-Ning Juan, Yu-Jen Chiu, Tsung-Jung Ho
OBJECTIVES: The protective effects and related mechanisms of Jing-Si herbal tea (JSHT) were investigated in cellular damage mediated by pro-inflammatory cytokines, including interleukin (IL)-1β, IL-6, and tumor necrosis factor-α, on normal human lung fibroblast by multiomic platform analysis. MATERIALS AND METHODS: The in silico high-throughput target was analyzed using pharmacophore models by BIOVIA Discovery Studio 2022 with ingenuity pathway analysis software...
2024: Tzu chi medical journal
https://read.qxmd.com/read/38645704/comparison-of-the-performance-of-miseq-and-novaseq-in-oral-microbiome-study
#35
JOURNAL ARTICLE
Hyejung Han, Hyo-Jung Lee, Keun-Suh Kim, Jin Chung, Hee Sam Na
OBJECTIVE: Next generation sequencing is commonly used to characterize the microbiome structure. MiSeq is most commonly used to analyze the microbiome due to its relatively long read length. Illumina also introduced the 250 × 2 chip for NovaSeq. The purpose of this study was to compare the performance of MiSeq and NovaSeq in the context of oral microbiome study. METHODS: Total read count, read quality score, relative bacterial abundance, community diversity, and correlation between two platforms were analyzed...
2024: Journal of Oral Microbiology
https://read.qxmd.com/read/38645300/clinical-utility-of-metagenomic-next-generation-sequencing-in-fever-of-undetermined-origin
#36
JOURNAL ARTICLE
Marilyne Daher, Roumen Iordanov, Mayar Al Mohajer, M Rizwan Sohail, Kristen Andrews Staggers, Ahmed Mufeed Hamdi
BACKGROUND: Metagenomic next-generation sequencing (mNGS) is a novel diagnostic tool increasingly used in the field of infectious diseases. Little guidance is available regarding its appropriate use in different patient populations and clinical syndromes. We aimed to review the clinical utility of mNGS in patients with a specific clinical syndrome and identify factors that may increase its utility. METHODS: We retrospectively reviewed charts of 72 non-immunocompromised adults hospitalized with the clinical syndrome of 'fever of undetermined origin' and underwent mNGS testing...
2024: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38645206/simultaneous-detection-of-pathogens-and-antimicrobial-resistance-genes-with-the-open-source-cloud-based-cz-id-pipeline
#37
Dan Lu, Katrina L Kalantar, Victoria T Chu, Abigail L Glascock, Estella S Guerrero, Nina Bernick, Xochitl Butcher, Kirsty Ewing, Elizabeth Fahsbender, Olivia Holmes, Erin Hoops, Ann E Jones, Ryan Lim, Suzette McCanny, Lucia Reynoso, Karyna Rosario, Jennifer Tang, Omar Valenzuela, Peter M Mourani, Amy J Pickering, Amogelang R Raphenya, Brian P Alcock, Andrew G McArthur, Charles R Langelier
Antimicrobial resistant (AMR) pathogens represent urgent threats to human health, and their surveillance is of paramount importance. Metagenomic next generation sequencing (mNGS) has revolutionized such efforts, but remains challenging due to the lack of open-access bioinformatics tools capable of simultaneously analyzing both microbial and AMR gene sequences. To address this need, we developed the Chan Zuckerberg ID (CZ ID) AMR module, an open-access, cloud-based workflow designed to integrate detection of both microbes and AMR genes in mNGS and whole-genome sequencing (WGS) data...
April 18, 2024: bioRxiv
https://read.qxmd.com/read/38645064/predicting-chromatin-conformation-contact-maps
#38
Alan Min, Jacob Schreiber, Anshul Kundaje, William Stafford Noble
Over the past 15 years, a variety of next-generation sequencing assays have been developed for measuring the 3D conformation of DNA in the nucleus. Each of these assays gives, for a particular cell or tissue type, a distinct picture of 3D chromatin architecture. Accordingly, making sense of the relationship between genome structure and function requires teasing apart two closely related questions: how does chromatin 3D structure change from one cell type to the next, and how do different measurements of that structure differ from one another, even when the two assays are carried out in the same cell type? In this work, we assemble a collection of chromatin 3D datasets-each represented as a 2D contact map- spanning multiple assay types and cell types...
April 14, 2024: bioRxiv
https://read.qxmd.com/read/38645014/increased-frequency-of-chd1-deletions-in-prostate-cancers-of-african-american-men-is-associated-with-rapid-disease-progression-without-inducing-homologous-recombination-deficiency
#39
Zoltan Szallasi, Miklos Diossy, Viktoria Tisza, Hua Li, Pranshu Sahgal, Jia Zhou, Zsofia Sztupinszki, Denise Young, Darryl Nuosome, Claire Kuo, Jiji Jiang, Yongmei Chen, Reinhard Ebner, Isabell Sesterhenn, Joel Moncur, Gregory Chesnut, Gyorgy Petrovics, Gregory T Klus, Gábor Valcz, Pier Nuzzo, Dezso Ribli, Judit Börcsök, Aurél Prósz, Marcin Krzystanek, Thomas Ried, Dávid Szüts, Kinza Rizwan, Salma Kaochar, Shailja Pathania, Alan D'Andrea, István Csabai, Shib Srivast, Matthew Freedman, Albert Dobi, Sandor Spisak
We analyzed genomic data derived from the prostate cancer of African and European American men in order to identify differences that may contribute to racial disparity of outcome and that could also define novel therapeutic strategies. In addition to analyzing patient derived next generation sequencing data, we performed FISH based confirmatory studies of Chromodomain helicase DNA-binding protein 1 ( CHD1 ) loss on prostate cancer tissue microarrays. We created CRISPR edited, CHD1 deficient prostate cancer cell lines for genomic, drug sensitivity and functional homologous recombination (HR) activity analysis...
April 1, 2024: Research Square
https://read.qxmd.com/read/38644974/case-report-marked-electroclinical-improvement-by-fluoxetine-treatment-in-a-patient-with-kcnt1-related-drug-resistant-focal-epilepsy
#40
Ilaria Mosca, Elena Freri, Paolo Ambrosino, Giorgio Belperio, Tiziana Granata, Laura Canafoglia, Francesca Ragona, Roberta Solazzi, Ilaria Filareto, Barbara Castellotti, Giuliana Messina, Cinzia Gellera, Jacopo C DiFrancesco, Maria Virginia Soldovieri, Maurizio Taglialatela
Variants in KCNT1 are associated with a wide spectrum of epileptic phenotypes, including epilepsy of infancy with migrating focal seizures (EIMFS), non-EIMFS developmental and epileptic encephalopathies, autosomal dominant or sporadic sleep-related hypermotor epilepsy, and focal epilepsy. Here, we describe a girl affected by drug-resistant focal seizures, developmental delay and behavior disorders, caused by a novel, de novo heterozygous missense KCNT1 variant (c.2809A > G, p.S937G). Functional characterization in transiently transfected Chinese Hamster Ovary (CHO) cells revealed a strong gain-of-function effect determined by the KCNT1 p...
2024: Frontiers in Cellular Neuroscience
keyword
keyword
83023
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.